Cytogen price target lowered by JMP

Cytogen Corp. was maintained by JMP Securities analyst Charles Duncan at a market outperform rating but the price target on the stock was reduced to $10 per share from $17 following second-quarter results. Cytogen shares lost 26.01 cents, or 5.12%, to $4.8199 on volume of 145,257 shares versus the three-month running average of 136,449 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.